Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000853 | uM | 12001.167 | 0.8885 | 0.5994 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00427 | uM | 12001.167 | 0.9885 | 0.9567 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0213 | uM | 12001.167 | 0.8781 | 0.5639 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.107 | uM | 12001.167 | 0.8778 | 0.5631 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.533 | uM | 12001.167 | 0.9060 | 0.6592 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 2.67 | uM | 12001.167 | 0.9265 | 0.7310 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12001.167 | 0.9145 | 0.6888 | 0.5287 | |
HCC1419 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12001.167 | 0.8952 | 0.6221 | 0.5287 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10693.154 | 0.9519 | 0.8899 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10693.154 | 0.9266 | 0.8322 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10693.154 | 0.9691 | 0.9290 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10693.154 | 0.9860 | 0.9679 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10693.154 | 0.9801 | 0.9543 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10693.154 | 0.9784 | 0.9505 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10693.154 | 0.9465 | 0.8776 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10693.154 | 0.9581 | 0.9040 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10693.154 | 0.9645 | 0.9186 | 0.8696 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 11936.154 | 0.9125 | 0.7901 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 11936.154 | 0.8830 | 0.7202 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 11936.154 | 0.9792 | 0.9498 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 11936.154 | 0.9516 | 0.8834 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 11936.154 | 0.9768 | 0.9438 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 11936.154 | 0.9389 | 0.8529 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 11936.154 | 0.9633 | 0.9116 | 0.8259 | |
HCC1428 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 11936.154 | 0.9208 | 0.8099 | 0.8259 |